|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/385 | (2006.01) |
| A61K 39/092 | (2013.01) | ||
| A61K 47/50 | (2017.01) | ||
| A61K2039/6037 | (2013.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61K 47/6415 | (2017.08) | ||
| A61K 47/646 | (2017.08) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 37/04 | (2018.01) |
| (11) | Patento numeris | 3443983 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18191446.6 |
| Europos patento paraiškos padavimo data | 2015-02-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-02-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-07-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201461939845 P | 2014-02-14 | US |
| (72) |
GU, Jianxin , US
KAINTHAN, Rajesh Kumar , US
KIM, Jin-Hwan , US
PRASAD, Avvari Krishna , US
YANG, Yu-ying , US
|
| (73) |
Pfizer Inc. ,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | IMMUNOGENIC GLYCOPROTEIN CONJUGATES |
| IMMUNOGENIC GLYCOPROTEIN CONJUGATES |